Search
for
Sort by
Research 511–540 of 809
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
- In vitro Hair Growth Promoting Effects of Naringenin and Hesperetin on Human Dermal Papilla Cells and Keratinocytes
- Oral Presentations
- Low-level laser therapy in androgenetic alopecia: narrative review
- Efficacy of low-level laser therapy in androgenetic alopecia – A randomized controlled trial
- Androgenetic Alopecia
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
- Alopecia areata as a clinical manifestation of autoimmune inflammation due to vitamin D deficiency
- Comparison of Alopecia areata in Human and Nonhuman Mammalian Species
- 35326 Exosome therapy for scalp hair growth—A review of the in vivo and in vitro evidence
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Wnt/β‐catenin and ERK pathway activation: A possible mechanism of photobiomodulation therapy with light‐emitting diodes that regulate the proliferation of human outer root sheath cells
- The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta‐analysis
- Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature
- Molecular functional analyses revealed essential roles of HSP90 and lamin A/C in growth, migration, and self-aggregation of dermal papilla cells
- Association of vitamin D level with alopecia areata
- Etiopathogenesis of Alopecia Areata
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Diagnosis and treatment of alopecia areata
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Exomic Sequencing of Immune-Related Genes Reveals Novel Candidate Variants Associated with Alopecia Universalis
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Hyaluronate - Minoxidil Conjugates for Transdermal Treatment of Hair Loss